Mutations in PAX2 associate with adult-onset FSGS

Moumita Barua, Emilia Stellacci, Lorenzo Stella, Astrid Weins, Giulio Genovese, Valentina Muto, Viviana Caputo, Hakan R. Toka, Victoria T. Charoonratana, Marco Tartaglia, Martin R. Pollak

Research output: Contribution to journalArticle

Abstract

FSGS is characterized by the presence of partial sclerosis of some but not all glomeruli. Studies of familial FSGS have been instrumental in identifying podocytes as critical elements in maintaining glomerular function, but underlying mutations have not been identified for all forms of this genetically heterogeneous condition. Here, exome sequencing in members of an index family with dominant FSGS revealed a nonconservative, disease-segregating variant in the PAX2 transcription factor gene. Sequencing in probands of a familial FSGS cohort revealed seven rare and private heterozygous single nucleotide substitutions (4% of individuals). Further sequencing revealed seven private missense variants (8%) in a cohort of individuals with congenital abnormalities of the kidney and urinary tract. As predicted by in silico structural modeling analyses, in vitro functional studies documented that several of the FSGS-associated PAX2 mutations perturb protein function by affecting proper binding to DNA and transactivation activity or by altering the interaction of PAX2 with repressor proteins, resulting in enhanced repressor activity. Thus, mutations in PAX2 may contribute to adult-onset FSGS in the absence of overt extrarenal manifestations. These results expand the phenotypic spectrum associated with PAX2 mutations, which have been shown to lead to congenital abnormalities of the kidney and urinary tract as part of papillorenal syndrome. Moreover, these results indicate PAX2 mutations can cause disease through haploinsufficiency and dominant negative effects, which could have implications for tailoring individualized drug therapy in the future.

Original languageEnglish
Pages (from-to)1942-1953
Number of pages12
JournalJournal of the American Society of Nephrology
Volume25
Issue number9
DOIs
Publication statusPublished - Sep 1 2014

Fingerprint

Mutation
Urinary Tract
PAX2 Transcription Factor
Repressor Proteins
Exome
Kidney
Haploinsufficiency
Podocytes
Sclerosis
Computer Simulation
Transcriptional Activation
Nucleotides
Drug Therapy
DNA
Genes
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Barua, M., Stellacci, E., Stella, L., Weins, A., Genovese, G., Muto, V., ... Pollak, M. R. (2014). Mutations in PAX2 associate with adult-onset FSGS. Journal of the American Society of Nephrology, 25(9), 1942-1953. https://doi.org/10.1681/ASN.2013070686

Mutations in PAX2 associate with adult-onset FSGS. / Barua, Moumita; Stellacci, Emilia; Stella, Lorenzo; Weins, Astrid; Genovese, Giulio; Muto, Valentina; Caputo, Viviana; Toka, Hakan R.; Charoonratana, Victoria T.; Tartaglia, Marco; Pollak, Martin R.

In: Journal of the American Society of Nephrology, Vol. 25, No. 9, 01.09.2014, p. 1942-1953.

Research output: Contribution to journalArticle

Barua, M, Stellacci, E, Stella, L, Weins, A, Genovese, G, Muto, V, Caputo, V, Toka, HR, Charoonratana, VT, Tartaglia, M & Pollak, MR 2014, 'Mutations in PAX2 associate with adult-onset FSGS', Journal of the American Society of Nephrology, vol. 25, no. 9, pp. 1942-1953. https://doi.org/10.1681/ASN.2013070686
Barua M, Stellacci E, Stella L, Weins A, Genovese G, Muto V et al. Mutations in PAX2 associate with adult-onset FSGS. Journal of the American Society of Nephrology. 2014 Sep 1;25(9):1942-1953. https://doi.org/10.1681/ASN.2013070686
Barua, Moumita ; Stellacci, Emilia ; Stella, Lorenzo ; Weins, Astrid ; Genovese, Giulio ; Muto, Valentina ; Caputo, Viviana ; Toka, Hakan R. ; Charoonratana, Victoria T. ; Tartaglia, Marco ; Pollak, Martin R. / Mutations in PAX2 associate with adult-onset FSGS. In: Journal of the American Society of Nephrology. 2014 ; Vol. 25, No. 9. pp. 1942-1953.
@article{48c3b50a65054e1cbbc5bccf3f28db17,
title = "Mutations in PAX2 associate with adult-onset FSGS",
abstract = "FSGS is characterized by the presence of partial sclerosis of some but not all glomeruli. Studies of familial FSGS have been instrumental in identifying podocytes as critical elements in maintaining glomerular function, but underlying mutations have not been identified for all forms of this genetically heterogeneous condition. Here, exome sequencing in members of an index family with dominant FSGS revealed a nonconservative, disease-segregating variant in the PAX2 transcription factor gene. Sequencing in probands of a familial FSGS cohort revealed seven rare and private heterozygous single nucleotide substitutions (4{\%} of individuals). Further sequencing revealed seven private missense variants (8{\%}) in a cohort of individuals with congenital abnormalities of the kidney and urinary tract. As predicted by in silico structural modeling analyses, in vitro functional studies documented that several of the FSGS-associated PAX2 mutations perturb protein function by affecting proper binding to DNA and transactivation activity or by altering the interaction of PAX2 with repressor proteins, resulting in enhanced repressor activity. Thus, mutations in PAX2 may contribute to adult-onset FSGS in the absence of overt extrarenal manifestations. These results expand the phenotypic spectrum associated with PAX2 mutations, which have been shown to lead to congenital abnormalities of the kidney and urinary tract as part of papillorenal syndrome. Moreover, these results indicate PAX2 mutations can cause disease through haploinsufficiency and dominant negative effects, which could have implications for tailoring individualized drug therapy in the future.",
author = "Moumita Barua and Emilia Stellacci and Lorenzo Stella and Astrid Weins and Giulio Genovese and Valentina Muto and Viviana Caputo and Toka, {Hakan R.} and Charoonratana, {Victoria T.} and Marco Tartaglia and Pollak, {Martin R.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1681/ASN.2013070686",
language = "English",
volume = "25",
pages = "1942--1953",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "9",

}

TY - JOUR

T1 - Mutations in PAX2 associate with adult-onset FSGS

AU - Barua, Moumita

AU - Stellacci, Emilia

AU - Stella, Lorenzo

AU - Weins, Astrid

AU - Genovese, Giulio

AU - Muto, Valentina

AU - Caputo, Viviana

AU - Toka, Hakan R.

AU - Charoonratana, Victoria T.

AU - Tartaglia, Marco

AU - Pollak, Martin R.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - FSGS is characterized by the presence of partial sclerosis of some but not all glomeruli. Studies of familial FSGS have been instrumental in identifying podocytes as critical elements in maintaining glomerular function, but underlying mutations have not been identified for all forms of this genetically heterogeneous condition. Here, exome sequencing in members of an index family with dominant FSGS revealed a nonconservative, disease-segregating variant in the PAX2 transcription factor gene. Sequencing in probands of a familial FSGS cohort revealed seven rare and private heterozygous single nucleotide substitutions (4% of individuals). Further sequencing revealed seven private missense variants (8%) in a cohort of individuals with congenital abnormalities of the kidney and urinary tract. As predicted by in silico structural modeling analyses, in vitro functional studies documented that several of the FSGS-associated PAX2 mutations perturb protein function by affecting proper binding to DNA and transactivation activity or by altering the interaction of PAX2 with repressor proteins, resulting in enhanced repressor activity. Thus, mutations in PAX2 may contribute to adult-onset FSGS in the absence of overt extrarenal manifestations. These results expand the phenotypic spectrum associated with PAX2 mutations, which have been shown to lead to congenital abnormalities of the kidney and urinary tract as part of papillorenal syndrome. Moreover, these results indicate PAX2 mutations can cause disease through haploinsufficiency and dominant negative effects, which could have implications for tailoring individualized drug therapy in the future.

AB - FSGS is characterized by the presence of partial sclerosis of some but not all glomeruli. Studies of familial FSGS have been instrumental in identifying podocytes as critical elements in maintaining glomerular function, but underlying mutations have not been identified for all forms of this genetically heterogeneous condition. Here, exome sequencing in members of an index family with dominant FSGS revealed a nonconservative, disease-segregating variant in the PAX2 transcription factor gene. Sequencing in probands of a familial FSGS cohort revealed seven rare and private heterozygous single nucleotide substitutions (4% of individuals). Further sequencing revealed seven private missense variants (8%) in a cohort of individuals with congenital abnormalities of the kidney and urinary tract. As predicted by in silico structural modeling analyses, in vitro functional studies documented that several of the FSGS-associated PAX2 mutations perturb protein function by affecting proper binding to DNA and transactivation activity or by altering the interaction of PAX2 with repressor proteins, resulting in enhanced repressor activity. Thus, mutations in PAX2 may contribute to adult-onset FSGS in the absence of overt extrarenal manifestations. These results expand the phenotypic spectrum associated with PAX2 mutations, which have been shown to lead to congenital abnormalities of the kidney and urinary tract as part of papillorenal syndrome. Moreover, these results indicate PAX2 mutations can cause disease through haploinsufficiency and dominant negative effects, which could have implications for tailoring individualized drug therapy in the future.

UR - http://www.scopus.com/inward/record.url?scp=84921665535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921665535&partnerID=8YFLogxK

U2 - 10.1681/ASN.2013070686

DO - 10.1681/ASN.2013070686

M3 - Article

C2 - 24676634

AN - SCOPUS:84921665535

VL - 25

SP - 1942

EP - 1953

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 9

ER -